Analyst firms · Barclays · INMD

Barclays INMD price target and rating history

InMode Ltd. (INMD) · Health Care

Barclays rates InMode Ltd. (INMD) Overweight with a $44 price target, as of its latest action on Dec 21, 2022. It has published 3 rating actions on INMD since July 2021, including 0 upgrades and 0 downgrades.

Current rating
Overweight
Price target
$44
Median target, all firms
Too few
Actions on INMD
3

Barclays price target on INMD

$120$82$4420222023202420252026
Barclays price target on INMD, each point a stated target, July 2021 to December 2022.

Every Barclays rating on INMD

Questions about Barclays and INMD

What is Barclays's price target for INMD?
Barclays's latest stated price target for InMode Ltd. (INMD) is $44, from its action on Dec 21, 2022.
What is Barclays's rating on INMD?
Barclays rates INMD Overweight, a bullish rating, as of Dec 21, 2022.
When did Barclays last change its view on INMD?
On Dec 21, 2022, Barclays starts coverage at Overweight, price target $44.

More INMD rating histories

All Barclays ratingsINMD news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.